{"id":"W1193538218","doi":"10.1182/blood.v122.21.3044.3044","title":"A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Etoposide; Internal medicine; CHOP; Gastroenterology; Cyclophosphamide; Epirubicin; Prednisone; Peripheral T-cell lymphoma; Chemotherapy; Surgery; Oncology; Immunology; T cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001532741,0.001109558,0.00162057,0.0003517919,0.0003262286,0.001005539,0.0008051107,0.0009196597,0.003127366],"category_scores_gemma":[0.0008019762,0.0004823805,0.001097259,0.0003501871,0.0008629559,0.00094236,0.0003578734,0.00276909,0.0006602461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006637593,"about_ca_system_score_gemma":0.001077514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005837696,"about_ca_topic_score_gemma":0.001603417,"domain_scores_codex":[0.9996504,0.0001658814,0.00001996853,0.00007121905,0.00002650593,0.00006607511],"domain_scores_gemma":[0.9993675,0.0000993112,0.00009336954,0.00005885408,0.00003579669,0.000345116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8408475,0.0637667,0.003750985,0.0007908485,0.001373651,0.0002213015,0.0002493889,0.001554481,0.02367483,0.0002231742,0.002018611,0.06152855],"study_design_scores_gemma":[0.7034606,0.2867906,0.005221474,0.00002722488,0.0005508835,0.0001708691,0.00004379097,0.0007521439,0.001387463,0.0001771911,0.00140056,0.00001718748],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917654,0.002696855,0.0005551583,0.0003962189,0.0001819717,0.002269054,0.000798562,0.00006280759,0.001273951],"genre_scores_gemma":[0.9905959,0.002287961,0.001359902,0.0005512394,0.0002136799,0.002076102,0.001326722,0.00002017337,0.001568377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003127366,"threshold_uncertainty_score":0.01046211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009784853628099706,"score_gpt":0.2432115664098138,"score_spread":0.2334267127817141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}